Logo image of ATRC

ATRICURE INC (ATRC) Stock Fundamental Analysis

NASDAQ:ATRC - Nasdaq - US04963C2098 - Common Stock - Currency: USD

38.39  -0.77 (-1.97%)

After market: 38.39 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ATRC. ATRC was compared to 190 industry peers in the Health Care Equipment & Supplies industry. The financial health of ATRC is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ATRC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ATRC had negative earnings in the past year.
ATRC had a positive operating cash flow in the past year.
ATRC had negative earnings in 4 of the past 5 years.
In multiple years ATRC reported negative operating cash flow during the last 5 years.
ATRC Yearly Net Income VS EBIT VS OCF VS FCFATRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a decent Return On Assets value of -7.34%, ATRC is doing good in the industry, outperforming 62.23% of the companies in the same industry.
ATRC has a Return On Equity of -9.70%. This is in the better half of the industry: ATRC outperforms 64.89% of its industry peers.
Industry RankSector Rank
ROA -7.34%
ROE -9.7%
ROIC N/A
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ATRC Yearly ROA, ROE, ROICATRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ATRC has a Gross Margin of 74.69%. This is amongst the best in the industry. ATRC outperforms 85.64% of its industry peers.
In the last couple of years the Gross Margin of ATRC has remained more or less at the same level.
ATRC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
ATRC Yearly Profit, Operating, Gross MarginsATRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATRC has been increased compared to 1 year ago.
Compared to 5 years ago, ATRC has more shares outstanding
The debt/assets ratio for ATRC is higher compared to a year ago.
ATRC Yearly Shares OutstandingATRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ATRC Yearly Total Debt VS Total AssetsATRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 7.73 indicates that ATRC is not in any danger for bankruptcy at the moment.
ATRC has a Altman-Z score of 7.73. This is amongst the best in the industry. ATRC outperforms 86.17% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ATRC is not too dependend on debt financing.
ATRC's Debt to Equity ratio of 0.15 is in line compared to the rest of the industry. ATRC outperforms 55.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 7.73
ROIC/WACCN/A
WACC8.98%
ATRC Yearly LT Debt VS Equity VS FCFATRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

ATRC has a Current Ratio of 3.65. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ATRC (3.65) is better than 67.02% of its industry peers.
A Quick Ratio of 2.62 indicates that ATRC has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.62, ATRC is in the better half of the industry, outperforming 60.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.65
Quick Ratio 2.62
ATRC Yearly Current Assets VS Current LiabilitesATRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.67% over the past year.
The Revenue has grown by 16.55% in the past year. This is quite good.
The Revenue has been growing by 15.05% on average over the past years. This is quite good.
EPS 1Y (TTM)6.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.9%
Revenue 1Y (TTM)16.55%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%16.64%

3.2 Future

Based on estimates for the next years, ATRC will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.54% on average per year.
The Revenue is expected to grow by 16.97% on average over the next years. This is quite good.
EPS Next Y11.03%
EPS Next 2Y16.57%
EPS Next 3Y23.02%
EPS Next 5Y9.54%
Revenue Next Year12.82%
Revenue Next 2Y12.74%
Revenue Next 3Y12.85%
Revenue Next 5Y16.97%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ATRC Yearly Revenue VS EstimatesATRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
ATRC Yearly EPS VS EstimatesATRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ATRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATRC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATRC Price Earnings VS Forward Price EarningsATRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATRC Per share dataATRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as ATRC's earnings are expected to grow with 23.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.57%
EPS Next 3Y23.02%

More info and screens

0

5. Dividend

5.1 Amount

ATRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATRICURE INC

NASDAQ:ATRC (2/21/2025, 8:02:11 PM)

After market: 38.39 0 (0%)

38.39

-0.77 (-1.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners98.87%
Inst Owner Change-6.31%
Ins Owners3.16%
Ins Owner Change-0.02%
Market Cap1.87B
Analysts85.33
Price Target55.72 (45.14%)
Short Float %2.48%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.1%
Min EPS beat(2)14.39%
Max EPS beat(2)65.82%
EPS beat(4)3
Avg EPS beat(4)15.21%
Min EPS beat(4)-20.17%
Max EPS beat(4)65.82%
EPS beat(8)7
Avg EPS beat(8)25.64%
EPS beat(12)8
Avg EPS beat(12)20.16%
EPS beat(16)9
Avg EPS beat(16)60.68%
Revenue beat(2)1
Avg Revenue beat(2)0.61%
Min Revenue beat(2)0%
Max Revenue beat(2)1.23%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.73%
Revenue beat(12)7
Avg Revenue beat(12)0.94%
Revenue beat(16)10
Avg Revenue beat(16)1.83%
PT rev (1m)2.71%
PT rev (3m)12.66%
EPS NQ rev (1m)1.48%
EPS NQ rev (3m)1.48%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)1.66%
Revenue NQ rev (3m)1.66%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.02
P/FCF N/A
P/OCF 153.35
P/B 4.06
P/tB 11.03
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.25
OCFY0.65%
SpS9.54
BVpS9.46
TBVpS3.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.34%
ROE -9.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.69%
FCFM N/A
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 125.23%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.65
Quick Ratio 2.62
Altman-Z 7.73
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.9%
EPS Next Y11.03%
EPS Next 2Y16.57%
EPS Next 3Y23.02%
EPS Next 5Y9.54%
Revenue 1Y (TTM)16.55%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%16.64%
Revenue Next Year12.82%
Revenue Next 2Y12.74%
Revenue Next 3Y12.85%
Revenue Next 5Y16.97%
EBIT growth 1Y-50.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year206.48%
EBIT Next 3Y55.14%
EBIT Next 5Y35.46%
FCF growth 1Y70%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y172.17%
OCF growth 3YN/A
OCF growth 5YN/A